SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions.

Frontiers in Bioscience : a Journal and Virtual Library
Richard B BankertNejat K Egilmez

Abstract

The successful engraftment of human tumors and human immunocompetent cells into severe combined immunodeficient (SCID) mice has led to the generation of a wide array of different experimental designs that have proven useful in studying the cell biology of human cancer, and for evaluating novel therapeutic approaches to the treatment of cancer. In this review five of the most frequently used embodiments of the SCID model are presented. The goals of this review are to discuss how each model has been utilized to study human cancer and its response to many different novel therapies, to provide an assessment of the strengths and limitations of each model, and to outline future directions with a focus on what is needed to overcome some of the current limitations and pitfalls of the SCID models.

Citations

May 31, 2003·International Journal of Hematology·Kazunori Imada
Dec 16, 2011·Journal of Translational Medicine·Bernard A FoxMary L Disis
May 13, 2015·International Journal of Oncology·Tsuyoshi ChijiwaMasato Nakamura
Aug 10, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shiwei GuoGang Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.